Peter Zeihan: Europe Goes Nuclear
We’ve got two major developments in Eurasia. We’re talking about Ukraine disabling two ships in the Caspian Sea and Poland getting EU approval to build…
Thought Leader: Peter Zeihan
Nearly one in five US adults are diagnosed with depression at some point in their lives. As the use of antidepressants have steadily risen since their introduction in the 1980s, what have we learned about depression? Is depression truly a “chemical imbalance” of the brain? And why do antidepressants work for some people and not others? Sanjay talks to Dr. Charles Raison, a professor of psychiatry at the University of Wisconsin-Madison, about what we now believe causes depression, and most importantly, what this means for how we treat the illness – from SSRIs to psychedelics and other emerging therapies.
Peter Zeihan: Europe Goes Nuclear
We’ve got two major developments in Eurasia. We’re talking about Ukraine disabling two ships in the Caspian Sea and Poland getting EU approval to build…
Thought Leader: Peter Zeihan
Dr. Sanjay Gupta’s Top Health Stories of 2025
From the resurgence of measles to a new way to treat pain, 2025 was a challenge for public health while still offering moments of hope. Sanjay…
Thought Leader: Sanjay Gupta
Ian Bremmer: The state of global conflict in 2025
On GZERO World, Ian Bremmer takes a hard look at the biggest global crises and conflicts that defined our world in 2025 with CNN’s Clarissa…
Thought Leader: Ian Bremmer